Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma
Crossref DOI link: https://doi.org/10.1038/srep46537
Published Online: 2017-04-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goričar, Katja
Kovač, Viljem
Dolžan, Vita
Text and Data Mining valid from 2017-04-19
Version of Record valid from 2017-04-19
Article History
Received: 7 September 2016
Accepted: 22 March 2017
First Online: 19 April 2017
Competing interests
: The authors declare no competing financial interests.